Clinical Trial Update: Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream [Phase 4]

View source ↗

Summary

Phase 4 trial update on using Imiquimod 3.75% cream for actinic keratoses; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Imiquimod 3.75% Cream (Imiquimod)

Snippet

Sponsor: Medical University of Graz | Conditions: Actinic Keratoses | Phase 4 | Status: COMPLETED